Table 2.
Observed responses in Box–Behnken design for rifapentine (RPT)-loaded nanostructured lipid carriers (NLCs).
Sample | Independent Variables | Dependent Variables | ||||
---|---|---|---|---|---|---|
X1 (mg) | X2 (mg) | X3 (mg) | Y1 (nm) | Y2 (%) | Y 3 | |
1 | 250 | 50 | 80 | 235 | 90.3 | 3.01 |
2 | 350 | 50 | 80 | 311 | 86.8 | 2.17 |
3 | 250 | 150 | 80 | 275 | 85.8 | 2.15 |
4 | 350 | 150 | 80 | 334 | 78.7 | 1.57 |
5 | 250 | 100 | 60 | 317 | 75.5 | 2.16 |
6 | 350 | 100 | 60 | 330 | 86.6 | 1.92 |
7 | 250 | 100 | 100 | 207 | 75.0 | 2.14 |
8 | 350 | 100 | 100 | 294 | 67.2 | 1.49 |
9 | 300 | 50 | 60 | 271 | 87.4 | 2.50 |
10 | 300 | 150 | 60 | 322 | 69.2 | 1.54 |
11 | 300 | 50 | 100 | 251 | 75.2 | 2.15 |
12 | 300 | 150 | 100 | 272 | 84.8 | 1.89 |
13 | 300 | 100 | 80 | 277 | 84.9 | 2.12 |
14 | 300 | 100 | 80 | 254 | 89.1 | 2.23 |
15 | 300 | 100 | 80 | 282 | 83.2 | 2.08 |
The independent variables were the amounts of solid lipid (X1), liquid lipid (X2), and surfactant (X3), while mean hydrodynamic particle size (Y1), encapsulation efficiency (Y2), and loading capacity (Y3) were the dependent variables in study.